Accelera Innovations (ACNV) Stock Price

Accelera Innovations Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Accelera Innovations has contracted by 80.5% per year over the past 3 years to 2,800.00 USD. For Accelera Innovations, the net margin of -70,457.2% is down versus -1,969.3% a few years ago.

Accelera Innovations stock price

Access this data via the Eulerpool API

Accelera Innovations business model & stock analysis

Accelera Innovations, Inc. operates as a development stage company with interests in providing healthcare services. The company is headquartered in Colorado Springs, Colorado. The company went IPO on 2014-10-31. The firm is focused on acquiring companies primarily in the post-acute care patient services and information technology services industries. The firm owns SCI Home Health, Inc. (SCI), doing business as Advance Lifecare Home Health, which offers personal care to patients in the Chicago, Illinois area.

Frequently asked questions about Accelera Innovations

Converted at the current exchange rate, the Accelera Innovations share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Accelera Innovations.

The profit cannot currently be calculated for Accelera Innovations.

The P/E ratio cannot be calculated for Accelera Innovations at the moment.

The P/S cannot be calculated for Accelera Innovations currently.

The Eulerpool Quality Score for Accelera Innovations is 2/10.

The ISIN of Accelera Innovations is US00434W1053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Accelera Innovations is ACNV. The ticker symbol is used to trade Accelera Innovations shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 31, 2014
ISIN
US00434W1053
Cusip
00434W105
Market capitalization
8,141.00 USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
147.05 %
Gross Margin
100.00 %
EBIT Margin
-67,792.86 %
Net Margin
-70,457.15 %
EPS (Earnings Per Share)
-0.04 USD
Net Debt / EBIT
-0.55
Debt/Equity
-0.44
Last updated Sep 29, 2026, 7:07 PM

Accelera Innovations Peer Group

Accelera Innovations Ticker

OTC · ACNV

Accelera Innovations FIGI

ACNV:US · BBG00325DVR7ACNV:PQ · BBG00325DW59ACNV:UV · BBG00325DW77